Medical and aesthetic procedural dermatology recommendations for transgender patients undergoing transition

被引：22

作者：

Dhingra, Nikhil ^{[1
,2
]}

Bonati, Lauren Meshkov ^{[3
]}

Wang, Erica B. ^{[4
,5
]}

Chou, Margaret ^{[1
]}

Jagdeo, Jared ^{[4
,5
,6
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[2] Spring St Dermatol, New York, NY USA

[3] SkinCare Phys, Chestnut Hill, MA USA

[4] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA

[5] Sacramento VA Med Ctr, Dermatol Serv, Mather, CA USA

[6] Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 06期

关键词：

aesthetic dermatology; affirmation; gender; injectable filler; neurotoxin; transgender; transgender dermatology; TOXIN TYPE-A; ANDROGENETIC ALOPECIA; SEXUAL-DIMORPHISM; BOTULINUM TOXIN; DOUBLE-BLIND; PHYSICAL TRANSFORMATION; POTENTIAL ROLE; YOUNG MEN; INJECTION; TISSUE;

D O I：

10.1016/j.jaad.2018.05.1259

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Transgender individuals may transition to their identified gender through social, hormonal, and procedural methods by using a multidisciplinary team of health care providers, including dermatologists. In this review, we discuss the medical and aesthetic dermatologic needs related to the transitioning of transgender patients and provide therapeutic and procedural recommendations. In addition to routine cutaneous conditions, dermatologists may need to treat hormonal therapy-related complications. Acumen for genital dermatology and familiarity with gender reassignment surgery is important for the dermatologist caring for a transgender patient. From a structural standpoint, transgender beauty poses a unique aesthetic task. We identify key differences in the facial structure and physique of males versus those of females. Dermatologists may have a tremendous impact on the lives of transgender individuals who seek to realize their gender identity.

引用

页码：1712 / 1721

页数：10

共 86 条

[1] Consensus Statement Regarding Storage and Reuse of Previously Reconstituted Neuromodulators
Alam, Murad
Bolotin, Diana
Carruthers, Jean
Hexsel, Doris
Lawrence, Naomi
Minkis, Kira
Ross, Edward Victor
[J]. DERMATOLOGIC SURGERY, 2015, 41 (03) : 321 - 326
[2] Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers
Alvarez, Hortensia
Marino, Ana
Garcia-Rodriguez, Jose F.
Vilas-Sueiro, Alejandro
Valcarce, Nieves
Llibre, Josep M.
[J]. AIDS, 2016, 30 (16) : 2561 - 2563
[3] Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia
Alves, Rubina
Grimalt, Ramon
[J]. DERMATOLOGIC SURGERY, 2016, 42 (04) : 491 - 497
[4] [Anonymous], 1980, J HUM EVOL, V9, P517
[5] Silicone granuloma of the face treated with minocycline
Arin, MJ
Bäte, J
Krieg, T
Hunzelmann, N
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) : S53 - S56
[6] An Analysis of Efficacy Data from Four Phase III Studies of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines
Baumann, Leslie
Brandt, Fredric S.
Kane, Michael A. C.
Donofrio, Lisa M.
[J]. AESTHETIC SURGERY JOURNAL, 2009, 29 (06) : S57 - S65
[7] Relationship Between Delayed Reactions to Dermal Fillers and Biofilms: Facts and Considerations
Beer, Kenneth
Avelar, Rui
[J]. DERMATOLOGIC SURGERY, 2014, 40 (11) : 1175 - 1179
[8] Adverse granulomatous reaction after cosmetic dermal silicone injection
Bigatà, X
Ribera, M
Bielsa, I
Ferrándiz, C
[J]. DERMATOLOGIC SURGERY, 2001, 27 (02) : 198 - 200
[9] Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety
Brandt, Fredric
Swanson, Neil
Baumann, Leslie
Huber, Barbara
[J]. DERMATOLOGIC SURGERY, 2009, 35 (12) : 1893 - 1901
[10] WHAT GIVES A FACE ITS GENDER
BROWN, E
PERRETT, DI
[J]. PERCEPTION, 1993, 22 (07) : 829 - 840

← 1 2 3 4 5 6 7 8 9 →